Capstone Wealth Management Group LLC Acquires 1,811 Shares of Intuitive Surgical, Inc. $ISRG

Capstone Wealth Management Group LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 151.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,006 shares of the medical equipment provider’s stock after purchasing an additional 1,811 shares during the period. Intuitive Surgical comprises about 0.6% of Capstone Wealth Management Group LLC’s portfolio, making the stock its 27th largest holding. Capstone Wealth Management Group LLC’s holdings in Intuitive Surgical were worth $1,344,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the business. Bingham Private Wealth LLC increased its holdings in Intuitive Surgical by 22.7% in the 3rd quarter. Bingham Private Wealth LLC now owns 842 shares of the medical equipment provider’s stock worth $342,000 after acquiring an additional 156 shares in the last quarter. Bourne Lent Asset Management Inc. lifted its holdings in Intuitive Surgical by 1.1% during the third quarter. Bourne Lent Asset Management Inc. now owns 26,943 shares of the medical equipment provider’s stock valued at $10,956,000 after purchasing an additional 300 shares in the last quarter. Maryland State Retirement & Pension System lifted its holdings in Intuitive Surgical by 12.7% during the third quarter. Maryland State Retirement & Pension System now owns 21,500 shares of the medical equipment provider’s stock valued at $8,743,000 after purchasing an additional 2,422 shares in the last quarter. Ritholtz Wealth Management lifted its holdings in Intuitive Surgical by 9.9% during the third quarter. Ritholtz Wealth Management now owns 6,361 shares of the medical equipment provider’s stock valued at $2,587,000 after purchasing an additional 571 shares in the last quarter. Finally, UNIVEST FINANCIAL Corp grew its position in shares of Intuitive Surgical by 16.1% in the third quarter. UNIVEST FINANCIAL Corp now owns 13,113 shares of the medical equipment provider’s stock valued at $5,332,000 after purchasing an additional 1,822 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently commented on ISRG. UBS Group reissued a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 13th. Royal Bank Of Canada decreased their price target on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 21st. Citigroup decreased their price target on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. Barclays reiterated an “overweight” rating and issued a $500.00 price objective (up from $485.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. Finally, JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $450.00 to $475.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $493.54.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $449.53 on Thursday. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The stock has a market cap of $155.83 billion, a PE ratio of 54.36, a P/E/G ratio of 3.10 and a beta of 1.45. The stock has a 50 day moving average price of $414.76 and a 200 day moving average price of $430.83.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm’s revenue was up 21.7% compared to the same quarter last year. During the same quarter last year, the business posted $2.40 earnings per share. As a group, analysts predict that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Craig H. Barratt sold 1,150 shares of the company’s stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $460.00, for a total value of $529,000.00. Following the completion of the sale, the director owned 1,150 shares of the company’s stock, valued at approximately $529,000. This represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of Intuitive Surgical stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the transaction, the vice president directly owned 1,026 shares in the company, valued at $464,993.46. This trade represents a 79.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 39,056 shares of company stock worth $17,585,864. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.